Vertera Spine announced initial successful outcomes using the COHERE® Cervical Interbody Fusion Device. Since “soft launch” in 2Q16, >400 COHERE devices have been implanted in anterior cervical fusion procedures in the U.S. The product received FDA 510(k) clearance in 3Q15.
COHERE features Scoria® biomaterial that seamlessly integrates with the bulk PEEK implant to support bony tissue ingrowth while retaining mechanical and imaging properties of traditional PEEK implants. COHERE is reported to be the first device in clinical use to be manufactured entirely out of PEEK and contain porosity.
Vertera Spine announced initial successful outcomes using the COHERE® Cervical Interbody Fusion Device. Since "soft launch" in 2Q16, >400 COHERE devices have been implanted in anterior cervical fusion procedures in the U.S. The product received FDA 510(k) clearance in 3Q15.
COHERE features Scoria® biomaterial that seamlessly integrates with...
Vertera Spine announced initial successful outcomes using the COHERE® Cervical Interbody Fusion Device. Since “soft launch” in 2Q16, >400 COHERE devices have been implanted in anterior cervical fusion procedures in the U.S. The product received FDA 510(k) clearance in 3Q15.
COHERE features Scoria® biomaterial that seamlessly integrates with the bulk PEEK implant to support bony tissue ingrowth while retaining mechanical and imaging properties of traditional PEEK implants. COHERE is reported to be the first device in clinical use to be manufactured entirely out of PEEK and contain porosity.
Copy to clipboard 
